Biofuture
BioFuture is an annual New York City conference produced by Demy-Colton Inc. that brings together 500+ biopharma and TechBio companies, investors, and industry leaders for Spotlight Panels, Seed Showcases, and one-to-one partnering meetings.
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Biofuture does
BioFuture is an annual biopharma and healthcare technology conference produced by Demy-Colton Inc. and held at Cure (345 Park Avenue South, New York City). The event convenes 500+ global attendees, 100+ speakers, and 50+ presenting companies across therapeutic areas including oncology, CNS/neurological disorders, immuno-oncology, autoimmune disease, longevity, and AI-driven drug discovery. Programming is structured around three core components: hour-long Spotlight Panel Discussions featuring 5 presenting companies per panel, a Seed Showcase for sub-$2M-funded startups with live pitch-doctor feedback, and one-to-one partnering meetings scheduled through the third-party Hello Partnering platform (EBD Group).
The business generates revenue through four streams: tiered presenting-company registration fees ($950–$2,500 per company), four-tier sponsorship packages (Diamond/Platinum/Gold/Silver) plus à la carte add-ons (lanyards, Wi-Fi branding, breakout rooms, exhibit space, sponsored email to a 33,000-contact database), on-floor exhibiting fees, and database/email monetization. Go-to-market is event-driven: company presentation slots and sponsorships are sold direct by Demy-Colton's business development team (Chief Business Officer Lila Taylor, Director Linda Burke), while investor and attendee registration is self-serve through the BioFuture website. Marketing relies on founding-board networks (Stifel, Aisling Capital, Pappas Capital, Scientific American, KKH Advisors), media partnerships (STAT News, BioWorld, GEN, Big4Bio, Scientific American), and direct outreach to Demy-Colton's curated life sciences database.
The company is privately held under Demy-Colton Inc., founded and led by Sara Jane Demy, with no disclosed funding rounds, no public ticker, and no parent-company ownership. The 2026 edition is scheduled for October 27–28 in New York City with a virtual partnering week November 3–5, indicating a hybrid format expansion. The addressable customer base spans biotech and biopharma companies (private and public), institutional and angel investors, pharma and healthcare executives, early-stage seed startups, and TechBio/digital-health ventures.
Biofuture firmographics
Firmographics- Name
- Biofuture
- Legal name
- Demy-Colton Inc.
- Website
- https://biofuture.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BioFuture is an annual New York City conference produced by Demy-Colton Inc. that brings together 500+ biopharma and TechBio companies, investors, and industry leaders for Spotlight Panels, Seed Showcases, and one-to-one partnering meetings.
- Ownership category
- akta.pro rank
Biofuture industry classification
Industry- Product category
- Biopharma Conference and Events
- NAICS
- Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Business Associations (813910)
- akta.pro primary industry
- Medical & Health Sciences Congresses (THAHAJAA)
- akta.pro secondary industries
- Life Sciences & Biotechnology Congresses (THAHAJAB), Healthcare & Medical Congresses (MPAGAGAF)
Keywords
Where Biofuture is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Biofuture business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Company Presentation Fees: BioFuture charges registration fees for companies presenting at the conference. Seed companies pay $950-$1,150; private and public companies pay $2,200-$2,500 depending on timing. Additional employees pay $500 each.
- Sponsorship Packages: Tiered sponsorship opportunities at Diamond, Platinum, Gold, and Silver levels with benefits including speaking opportunities, program development input, registrations, logo placement on signage and materials, and flexible add-ons such as partnering system, lanyards, exhibit space, breakout rooms, sponsored emails, and Wi-Fi branding.
- Exhibiting Fees: Flexible exhibit space on the main conference floor available for purchase; companies can reserve space to showcase their products and engage with attendees.
- Sponsored Email to Database: Sponsors can purchase sponsored email placements to Demy-Colton's 33,000-person database, providing targeted marketing exposure to a curated life sciences audience.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | One time/ perpetual license | Seed Company Registration |
| One time/ perpetual license | One time/ perpetual license | Private Company Registration |
| One time/ perpetual license | One time/ perpetual license | Public Company Registration |
| One time/ perpetual license | One time/ perpetual license | Diamond Sponsorship |
| One time/ perpetual license | One time/ perpetual license | Platinum Sponsorship |
| One time/ perpetual license | One time/ perpetual license | Gold Sponsorship |
| One time/ perpetual license | One time/ perpetual license | Silver Sponsorship |
| Other | One time/ perpetual license | Additional Add-on Sponsorship Options |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Biofuture product offering
Product offeringCore offering
Biofuture is an annual in-person healthcare innovation conference held in New York City that convenes biopharma companies, investors, pharma executives, and TechBio startups for spotlight panel presentations, seed showcases, and one-to-one partnering meetings. The event enables structured deal-making through the Hello Partnering platform and offers tiered sponsorship and registration opportunities for biotech, AI-driven drug discovery, and digital health organizations.
Product overview
BioFuture is an annual in-person conference event held in New York City at Cure (345 Park Avenue South) that serves as a platform for the biopharma, digital health, and life sciences ecosystem. The event features three main components: (1) Spotlight Panel Discussions - hour-long curated sessions where 5 selected companies present their innovations followed by interactive panel dialogue; (2) Seed Showcase - a dedicated track for early-stage companies to pitch with expert feedback; and (3) Hello Partnering Platform - an online scheduling system enabling one-to-one meetings between attendees. The conference attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers across therapeutic areas including oncology, CNS/neurological, AI drug discovery, longevity, and immunology.
Differentiator
Problem solved
Functional benefit
Products and services
- BioFuture Annual Conference Annual in-person healthcare and biopharma conference held in New York City that brings together innovators, investors, and industry leaders to discuss the future of biopharma, digital medicine, AI, and healthcare technology. Attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers per edition.
- Spotlight Panel Discussions Hour-long interactive panel discussions featuring 5 selected companies delivering 5-minute introductions followed by moderator-led group dialogue and audience Q&A, organized by therapeutic focus areas such as cancer therapeutics, CNS health, AI drug discovery, and longevity.
- Seed Showcase High-visibility platform for early-stage life sciences startups (under $2M funding, less than 3 years old, fewer than 5 employees) to deliver 5-minute company presentations and receive real-time feedback from investor and industry Pitch Doctors.
- Hello Partnering Platform (BioFuture Edition) Online partnering system enabling one-to-one meetings between attendees, investors, and presenting companies, with options for virtual meetings and pre-recorded company presentations for on-demand viewing. Supports both in-person meetings during the conference and a virtual partnering week after the event.
Quantifiable outcome
- 500+ global attendees per edition
- +4 more outcomes
Companies that use Biofuture
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles4 records
Biofuture technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biofuture partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- Ernst & Young LLP (EY)coreEY is a founding sponsor and sits on the BioFuture founding board through Tim Opler (Managing Director). EY provides strategic insights, reputation, and relationships to the conference ecosystem and is a Gold-level sponsor of BioFuture 2026.
- Scientific AmericancoreJeremy A. Abbate, VP & Publisher of Scientific American, is on the BioFuture founding board. Scientific American is a founding media partner providing brand credibility and media amplification for the conference.
- KKH AdvisorscoreKimberly Ha, CEO & Founder of KKH Advisors, is on the BioFuture founding board. KKH Advisors provides strategic guidance on the intersection of biopharma and digital/tech evolution and contributes to program content development.
- Cure (Healthcare Innovation Ecosystem)coreCure is the venue partner and headquarters for BioFuture. Located at 345 Park Avenue South, NYC, Cure is a premier healthcare innovation ecosystem providing knowledge, infrastructure, and tools to accelerate progress toward cures. The campus houses flagship event venues and is home to healthcare organizations from idea stage to public companies.
- Hello Partnering (EBD Group)coreHello Partnering is the partnering platform used by BioFuture to enable one-to-one meeting scheduling between attendees, investors, and presenting companies. The platform supports both in-person meetings during the conference and virtual partnering weeks after the event.
- Hotel AKA NomadminorHotel AKA Nomad is BioFuture's preferred hotel for attendees. Located at 31st Street and Madison Avenue, it is a five-minute walk to Cure and offers both hotel accommodations and furnished residences with business, wellness, and lifestyle amenities.
- Regeneron PharmaceuticalsminorRegeneron is a past sponsor and supporter of BioFuture. Nouhad Husseini, Senior VP BD & Corporate Strategy at Regeneron, has participated as a speaker. Regeneron's sponsorship and speaker participation signal pharma industry endorsement of the conference.
- STAT NewsminorSTAT News is a media partner for BioFuture, providing editorial coverage and amplifying event announcements, speaker lineups, and key discussions to its healthcare-focused readership.
- BioWorldminorBioWorld is a media partner for BioFuture, helping amplify conference content and announcements to its audience of life sciences industry professionals and investors.
- Demy-ColtoncoreDemy-Colton is the conference organizer and producer of BioFuture. Led by Sara Jane Demy (CEO & Founder) and a professional staff team, Demy-Colton manages all aspects of conference production, partnering platform operation, sponsorship sales, and program development.
- Venture Valuation / Patrik FreiminorPatrik Frei, CEO of Venture Valuation, manages the partnering function at BioFuture. Venture Valuation provides partnering coordination and business development support for the conference's one-to-one meeting program.
- Thermo Fisher ScientificminorThermo Fisher Scientific (PPD) is listed as a past sponsor, supporting BioFuture's mission to connect the life sciences community.
- Hogan LovellsminorHogan Lovells is listed as a past sponsor and supporter of BioFuture. The law firm provides legal and regulatory expertise, and its professionals (including Alice Valder Curran) participate as speakers. Their endorsement signals regulatory and compliance community support for the conference.
- Charles River LaboratoriesminorCharles River Laboratories is listed as a past sponsor and speaker contributor at BioFuture. Julie Frearson, SVP & CSO at Charles River Laboratories, participates as a speaker, providing drug discovery and development expertise to the program.
- NYC Health + Hospitals / JacobiminorNYC Health + Hospitals (Jacobi/NCB) is a registered attendee and participant at BioFuture. Komal Bajaj, Chief Quality Officer, serves on panels discussing longevity therapeutics and health equity.
Scale indicators8 records
Recent moves6 records
Expansion highlights4 records
Biofuture competitors and assessment
Company assessmentBroad incumbents
- Informa (Life Sciences portfolio): A large events and media group whose life-sciences portfolio (e.g., CPHI, BIO-Europe partners, festivals including Citeline events) competes with BioFuture for sponsor budgets and producing-company attention at much larger scale.
- J.P. Morgan Healthcare Conference: The largest annual healthcare investor conference, held every January in San Francisco. It is the dominant deal-making forum BioFuture explicitly competes with for the same biotech/investor audience, but at vastly larger scale (~10,000+ attendees).
- Jefferies Healthcare Conference: An investment-bank-hosted annual healthcare/life-sciences conference presenting public and private biotechs to institutional investors. Mirrors BioFuture's investor-conference positioning but operates at greater scale and brand.
- BIO International Convention: BIO's flagship annual convention brings together the global biotech industry for partnering, programming and exhibition. It targets the same biopharma executives, investors and presenting companies as BioFuture, with substantially broader international attendance.
Direct peers
- Biotech Showcase (EBD Group): An investor and partnering conference held annually in San Francisco alongside J.P. Morgan, featuring presenting biotech companies and one-to-one meetings through the partneringONE platform. Closest direct analogue to BioFuture's investor-facing, presentation-driven format.
- BIO-Europe: A Europe-based partnering conference organized by the Biotechnology Innovation Organization, focused on one-to-one meetings between biotechs and pharma/investors via EBD Group's partneringONE platform — directly analogous to BioFuture's Hello Partnering model.
- RESI Conference (Life Science Nation): Redefining Early Stage Investments is an early-stage life-sciences investor conference with partnering and pitch formats targeting seed and Series A biotechs — the same presenting-company segment as BioFuture's Seed Showcase.
- BIO CEO & Investor Conference: Annual conference focused on publicly traded biotech companies and institutional investors, with company presentations and one-on-one partnering. Competes with BioFuture for the public-company-presentation audience.
- BioCentury (events arm): BioCentury produces proprietary investor events such as the BioCentury Grand Rounds and Back to School sessions, plus the BCIQ Summit, targeting the same biotech/investor audience as BioFuture but with a heavier editorial/content focus.
Regional players
- BIO Asia: BIO's Asia-Pacific biotech partnering conference. Same model (presentations + partnering + investor focus) but in Asia, where BioFuture does not currently compete and where it could expand if pursuing geographic growth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Biofuture social profiles
Digital presenceBiofuture financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biofuture leadership team
Management profileNumber of profiles
Profiles10 records
Biofuture funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biofuture M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biofuture
What does Biofuture do?
Biofuture is an annual in-person healthcare innovation conference held in New York City that convenes biopharma companies, investors, pharma executives, and TechBio startups for spotlight panel presentations, seed showcases, and one-to-one partnering meetings. The event enables structured deal-making through the Hello Partnering platform and offers tiered sponsorship and registration opportunities for biotech, AI-driven drug discovery, and digital health organizations.
Is Biofuture a public or private company?
Biofuture is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biofuture founded?
Biofuture was founded in 2021. It employs 251 to 500 people.
Where is Biofuture based?
Biofuture is headquartered in New York, United States, in the North America region.
How does Biofuture make money?
Four revenue lines are on record. Company Presentation Fees are the primary driver. The others are sponsorship Packages, exhibiting Fees and sponsored Email to Database.
Who are Biofuture's main competitors?
Broad incumbents on record are Informa (Life Sciences portfolio), J.P. Morgan Healthcare Conference, Jefferies Healthcare Conference and BIO International Convention. Direct peers are Biotech Showcase (EBD Group), BIO-Europe, RESI Conference (Life Science Nation), BIO CEO & Investor Conference and BioCentury (events arm). BIO Asia is listed as a regional player.
Does Biofuture have an API?
No public API is recorded for Biofuture.
What industry is Biofuture in?
Biofuture's product category is Biopharma Conference and Events. Its primary akta.pro industry code is THAHAJAA, Medical & Health Sciences Congresses, with a secondary code of THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 813.